Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases is a research paper published in Drug Delivery and Translational Research (2021). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA218617
National Institutes of Health
Grant: NS108813
NCI NIH HHS
Grant: R37 CA218617
National Institutes of Health
Grant: 5R01CA108813-02
In Vivo Targeted Vaccines for Tumor Immunotherapy
National Institutes of Health
Grant: 5R37CA218617-07
Impact of Fn14-targeted Nanoparticles for Triple-Negative Breast Cancer
FWCI
1.44
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals